Terms: = Thyroid cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Prognosis
2424 results:
1. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
[TBL] [Abstract] [Full Text] [Related]
2. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract] [Full Text] [Related]
3. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
4. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
5. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract] [Full Text] [Related]
6. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.
Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X
Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918
[TBL] [Abstract] [Full Text] [Related]
8. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Fang Q; Yuan J; Zhang X; Dai L; Luo R; Xu C
Oral Oncol; 2024 May; 152():106810. PubMed ID: 38631065
[TBL] [Abstract] [Full Text] [Related]
9. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
[TBL] [Abstract] [Full Text] [Related]
11. BRAF
Zhao H; Liu CH; Lu Y; Liu SZ; Yeerkenbieke P; Cao Y; Xia Y; Gao LY; Liu YW; Liu ZW; Chen SG; Liang ZY; Li XY
Oral Oncol; 2024 May; 152():106755. PubMed ID: 38547780
[TBL] [Abstract] [Full Text] [Related]
12. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract] [Full Text] [Related]
13. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
14. Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer.
Narui K; Satake T; Ishikawa T; Muto M; Tsunoda Y; Yamada A; Kawashima K; Uenaka N; Fujiwara Y; Oshi M; Adachi S; Suzuki C; Wada T; Yamamoto S; Tanabe M; Maegawa J; Endo I
Breast Cancer; 2024 May; 31(3):476-484. PubMed ID: 38512534
[TBL] [Abstract] [Full Text] [Related]
15. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
[TBL] [Abstract] [Full Text] [Related]
16. LncRNAs associated with lymph node metastasis in thyroid cancer based on TCGA database.
Liu R; Liu W; Xue J; Jiang B; Wei Y; Yin Y; Li P
Pathol Res Pract; 2024 Apr; 256():155255. PubMed ID: 38492360
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
Su H; Hao JJ; Xu YB; Zhang FH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
[TBL] [Abstract] [Full Text] [Related]
18. Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.
Wang R; Cheng L; He L; Du C; Wang H; Peng B; Yu X; Liu W; Luo W; Ran H; Yang L
J Nanobiotechnology; 2024 Mar; 22(1):110. PubMed ID: 38481281
[TBL] [Abstract] [Full Text] [Related]
19. Correlation between genetic alterations and clinicopathological features of papillary thyroid carcinomas.
Shang S; Yang H; Chen M; Wu J; Shi X; Li X; Feng N; Zheng Z; Liu H; Zhang Y
J Int Med Res; 2024 Mar; 52(3):3000605241233166. PubMed ID: 38456650
[TBL] [Abstract] [Full Text] [Related]
20. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
[TBL] [Abstract] [Full Text] [Related]
[Next]